Early & Managed Access Programmes is a conference dedicated to the regulatory, ethical and management aspects of early and managed access programmes.
Topics
- Optimise your pre-approved access programme by streamlining your approach to clinical operations
- Navigate the highly diverse European regulatory landscape
- View your pre-approved access programme as part of a continuum of development by effectively and compliantly collecting Real World Data
- Plan for success by setting clear objectives and developing your skills in cross-functional collaboration
- Ensure your pre-approved access programme is truly patent- centric by discovering how to engage patients at each stage of the programme, from early planning to close out, and beyond
- Safeguard your patient’s access to medicine by hearing best practice case studies in logistical strategy
Who should Attend
Industry professionals from:
- Contact Research Organisations
- SME and Big Pharma and Biotech, including
- Medical Affairs
- Clinical/Medical Operations
- Market Access
- Regulatory Affairs
- Pharmacovigilance
- MAP Providers
- Patient Advocates
- Regulatory Consultants
- Logistics Providers
